Ergoteles’s Silicon Laboratories SLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6,100
Closed -$1.07M 1480
2023
Q1
$1.07M Buy
6,100
+4,476
+276% +$752K 0.04% 474
2022
Q4
$220K Sell
1,624
-30,870
-95% -$4.06M 0.01% 1033
2022
Q3
$4.01M Buy
32,494
+22,576
+228% +$3.02M 0.14% 157
2022
Q2
$1.39M Sell
9,918
-16,623
-63% -$2.33M 0.04% 413
2022
Q1
$3.99M Sell
26,541
-1,178
-4% -$188K 0.15% 154
2021
Q4
$5.72M Buy
27,719
+22,853
+470% +$4.21M 0.22% 103
2021
Q3
$682K Buy
4,866
+66
+1% +$9.9K 0.03% 477
2021
Q2
$736K Buy
+4,800
New +$671K 0.02% 624
2020
Q4
Sell
-2,800
Closed -$274K 889
2020
Q3
$274K Buy
+2,800
New +$282K 0.04% 379

Other funds holding SLAB

Ergoteles's SLAB Position: Q2 2023 in Review

Ergoteles sold out of Silicon Laboratories (SLAB) in Q2 2023, closing a stake of 6,100 shares — an estimated $1.07M sold.

Ergoteles first reported a position in SLAB in Q3 2020 and held it in 9 quarters. The position peaked at $5.72M in Q4 2021. 321 funds tracked by Wall St. Rank hold SLAB as of Q2 2023.

  • Ergoteles reported no remaining Silicon Laboratories position as of Q2 2023 after selling out during the quarter.
  • Ergoteles sold 6,100 Silicon Laboratories shares in Q2 2023, an estimated $1.07M.
  • Ergoteles first reported a position in Silicon Laboratories in Q3 2020 and held it in 9 quarters.
  • Ergoteles's Silicon Laboratories position peaked at $5.72M in Q4 2021.
  • 321 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.